National Drug Schedules

including but not limited to palonosetron hydrochloride

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

Including but not limited to:
Amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin, ticarcillin, penicillin G (benzyl penicillin), procaine penicillin G.
 

For veterinary use, when recommended in cats.

Including: Dimenoxadol, Dioxaphetyl butyrate, Dextropropoxyphene 
 

Including: Proheptazine; but not including: Ethoheptazine and its salts; Metethoheptazine and its salts; Metheptazine and its salts

Including: Ketamine

Including but not limited to glycerol phenylbutyrate, phenylbutyrate sodium.

In preparations for parenteral use or ophthalmic use in concentrations greater than 2.5%.

Including: Allylprodine; Alphameprodine; Alphaprodine; Anileridine; Betameprodine; Betaprodine; Benzethidine; Diphenoxylate; Difenoxin; Etoxeridine; Furethidine;  Hydroxypethidine; Ketobemidone; Methylphenylisonipecotonitrile; Morpheridine; Norpethidine; Pethidine; Phenoperidine; Piminodine; Properidine; Trimeperidine; Pethidine Intermediate C; but not including: Carperidine and its salts; Oxpheneridine and its salts
 

For human use - except preparations for oral or topical use only.

except:
1) derivatives of cannabis as defined in subsection 2(1) of the Cannabis Act that are exempt from the application of the Cannabis Act under the Industrial Hemp Regulations and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or

2) anything referred to in Schedule 2 to the Cannabis Act that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid.

*Note: this listing is copied from the Health Canada Prescription Drug List and applies to products that have received a Notice of Compliance and Drug Identification Number and been classified as prescription drugs by Health Canada. Cannabis products, as defined in the Cannabis Act and its regulations, are not granted a Notice of Compliance and Drug Identification Number by Health Canada and are considered outside the scope of the National Drug Schedules.

When recommended for topical use.

When indicated for administration by injection.

For human use - except for topical use or for local action in the oral cavity or nasal passages.

For veterinary use - when sold in combination with other medicinal ingredients.

for human, ophthalmic use

When recommended for the treatment of renal tubular acidosis and kidney stones.

For veterinary use - when sold or recommended for administration to cats.

Except in preparations for topical use on the skin.

In preparations for injection.

for topical use on mucous membranes, except lozenges

For human use.

For veterinary use - except when sold for the treatment of the tapeworm Anoplocephala perfoliata in horses.

for ophthalmic or parenteral use

for topical use on mucous membranes, except lozenges

For human use.

Including but not limited to ethopropazine.

For veterinary use - except when recommended for use in progesterone implants indicated for growth promotion, melengestrol acetate in feed for the suppression of estrus in beef heifers.

For human use.

For internal use.

Including but not limited to: Alprostadil, bimatoprost, cloprostenol, dinoprostone, epoprostenol, fluprostenol, latanoprost, latanoprostene bunod, lubiprostone, misoprostol, tafluprost, travoprost, treprostinil, unoprostone.

Including but not limited to prucalopride succinate.